Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer

Clinical Trial for Prostate Cancer

NCT00076531 ·Status: COMPLETED ·Phase: PHASE3

Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

NCT00937768 ·Status: TERMINATED ·Phase: PHASE2

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

NCT05803941 ·Status: RECRUITING ·Phase: PHASE4

Real-life Study of Patients After 3-months of Leuprorelin 5mg Implant in Prostate Cancer

NCT03990194 ·Status: WITHDRAWN

Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

NCT01161563 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer

NCT02085252 ·Status: COMPLETED ·Phase: PHASE3

Hormone Therapy in Treating Patients With Advanced Prostate Cancer

NCT00003026 ·Status: COMPLETED ·Phase: PHASE3

GP Extended Action Triptorelin

NCT01673984 ·Status: TERMINATED ·Phase: PHASE4

Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c

NCT00817739 ·Status: COMPLETED ·Phase: PHASE2

Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer

NCT00175383 ·Status: UNKNOWN ·Phase: PHASE3

Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients

NCT01313273 ·Status: TERMINATED ·Phase: PHASE3

A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma

NCT00001266 ·Status: COMPLETED ·Phase: PHASE2

Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer

NCT01326312 ·Status: TERMINATED ·Phase: PHASE2

Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer

NCT02212197 ·Status: COMPLETED ·Phase: PHASE2

Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer

NCT03516812 ·Status: COMPLETED ·Phase: PHASE2

Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer

NCT03261999 ·Status: COMPLETED ·Phase: PHASE3

Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624

NCT05781217 ·Status: RECRUITING ·Phase: PHASE3

A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer

NCT00036543 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer

NCT00415246 ·Status: TERMINATED ·Phase: PHASE3

A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer

NCT02083185 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer

NCT00751790 ·Status: COMPLETED ·Phase: PHASE3

Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer

NCT01819285 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate Cancer

NCT06441994 ·Status: RECRUITING ·Phase: PHASE1

Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer

NCT00363285 ·Status: UNKNOWN ·Phase: PHASE3

PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer

NCT00379561 ·Status: COMPLETED ·Phase: PHASE1